StockOtters
StockOttersSupply Chain Map
GeneOne Life Science, Inc. logo

GeneOne Life Science, Inc.

011000.KS

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
27
Cost of Revenue
35
Gross Profit
-8
Gross Margin
-30.4%
Operating Income
-32
Operating Margin
-120.5%
Net Income
-36
Net Margin
-135.9%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-21
EBITDA Margin
-80.2%

2023

12/31/2023

Revenue
30
Cost of Revenue
36
Gross Profit
-6
Gross Margin
-19.3%
Operating Income
-36
Operating Margin
-120.3%
Net Income
-58
Net Margin
-193.4%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-48
EBITDA Margin
-158.4%

2022

12/31/2022

Revenue
37
Cost of Revenue
30
Gross Profit
7
Gross Margin
19.2%
Operating Income
-30
Operating Margin
-82.3%
Net Income
-29
Net Margin
-78.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-19
EBITDA Margin
-52.0%

2021

12/31/2021

Revenue
29
Cost of Revenue
22
Gross Profit
7
Gross Margin
22.6%
Operating Income
-21
Operating Margin
-71.1%
Net Income
-12
Net Margin
-41.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-5
EBITDA Margin
-16.9%

2020

12/31/2020

Revenue
31
Cost of Revenue
23
Gross Profit
9
Gross Margin
27.5%
Operating Income
-14
Operating Margin
-44.5%
Net Income
-14
Net Margin
-44.9%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-10
EBITDA Margin
-32.9%